Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single‐centre real‐world study
Diabetic Medicine · 2024
DOI: 10.1111/dme.15333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2024. Verfasst von Elif Eviz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology and Diabetes, Koc University Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Blood Glucose Self-Monitoring, Feasibility Studies. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aims
Time in Tight Range (TITR) is a novel glycaemic metric in monitoring type 1 diabetes (T1D) management. The aim of this study was to assess the attainability of the TITR target in children and adolescents using the advanced hybrid closed loop (AHCL).
Methods
The 2128‐day CGM data from 56 children and adolescents with T1D using AHCL (Minimed‐780G) were analysed. Time in Range (TIR) (3.9–10 mmol/L), TITR (3.9–7.7 mmol/L), and other glycaemic parameters were separately analysed in terms of whole day, daytime (06.00–23:59), and nighttime (00.00–05.59) results. The participants were divided into two groups by autocorrection rate where Group 1 had a rate of 50% and >60% were 87% and 52%, respectively. When those with TITR >60% ( n : 29) and those without ( n : 27) were evaluated in terms of hypoglycaemia, no statistically significant difference was found in time below range (TBR) 3–3.9 mmol/L (0.3% vs. 2.1%, p : 0.084) and TBR < 3 mmol/L (0.47% vs. 0.3%, p : 0.298). Group 1 had a significantly higher TIR and TITR compared to Group 2 (82.6 ± 6.1% vs. 75.6 ± 8.6%, p : 0.008 and 62.1 ± 7.5% vs. 53.8 ± 7.5%, p : 0.002, respectively).
Conclusions
Most children and adolescents on AHCL achieved the 50% target for TITR whereas more than half achieved the >60% target. A target of >50% for TITR seems realistic in children with T1D using AHCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Endocrinology and Diabetes, Koc University Hospital, Istanbul, Turkey.
- Koc University School of Medicine, Istanbul, Turkey.
ORCID-Profile: Elif Eviz, Gul Yesiltepe Mutlu
Zitieren
APA
Eviz, E., Killi, N. E., Karakus, K. E., Can, E., Gokce, T., Yesiltepe Mutlu, G., & Hatun, S. (2024). Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single‐centre real‐world study. Diabetic Medicine. https://doi.org/10.1111/dme.15333
Vancouver
Eviz E, Killi NE, Karakus KE, Can E, Gokce T, Yesiltepe Mutlu G, et al. Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single‐centre real‐world study. Diabetic Medicine. 2024. doi:10.1111/dme.15333
BibTeX
@article{Eviz2024,
author = {Eviz, Elif and Killi, Nesrin Ecem and Karakus, Kagan Ege and Can, Ecem and Gokce, Tugba and Yesiltepe Mutlu, Gul and Hatun, Sukru},
title = {Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single‐centre real‐world study},
journal = {Diabetic Medicine},
year = {2024},
doi = {10.1111/dme.15333}
}
EUVIMED